Results 141 to 150 of about 12,401 (156)

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of Hepatology, 2017
Julian Schulze Zur Wiesch, Markus Cornberg, Thomas Berg   +2 more
exaly  

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Lancet, The, 2013
Patrick Marcellin, Maria Buti Ferret, Nezam Afdhal   +2 more
exaly  

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Moupali Das, Kenneth Mayer, Robert Grant   +2 more
exaly  

A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection

Expert Opinion on Investigational Drugs, 2012
Ayesha Bm Kharsany, Tanuja Narayansamy Gengiah, Cheryl Baxter   +2 more
exaly  

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate/emtricitabine/tenofovir disoproxil fumarate

Reactions Weekly, 2019
openaire   +1 more source

Tenofovir disoproxil fumarate: A nucleotide reverse transcriptase inhibitor for the treatment of HIV infection

Clinical Therapeutics, 2002
Horatio B Fung
exaly  

Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis

Drugs, 2013
Plosker Greg L
exaly  

Tenofovir-disoproxil-fumarate

Reactions Weekly, 2022
openaire   +1 more source

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B

Expert Review of Anti-Infective Therapy, 2010
Paul A Pham
exaly  

Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study

Journal of Hepatology, 2017
Hie-Won Hann, Petr Husa, Cihan Yurdaydin   +2 more
exaly